Article

Daily Medication Pearl: Donepezil (Aricept)

Donepezil (Aricept) is an acetylcholinesterase inhibitor indicated for the treatment of dementia related to Alzheimer disease.

Medication Pearl of the Day: Donepezil (Aricept)

Indication: Donepezil (Aricept) is an acetylcholinesterase inhibitor indicated for the treatment of dementia related to Alzheimer disease. Efficacy has been demonstrated in patients with mild, moderate, and severe Alzheimer disease.

Insight:

  • Dosing: 5 mg or 10 mg administered once daily.
  • Dosage forms: Tablets 5 mg, 10 mg, and 23 mg. Orally disintegrating tablets 5 mg and 10 mg.
  • Adverse events: The most common adverse reactions in clinical studies of donepezil are nausea, diarrhea, insomnia, vomiting, muscle cramps, fatigue, and anorexia.
  • Mechanism of action: Donepezil hydrochloride is postulated to exert its therapeutic effect by enhancing cholinergic function. This is accomplished by increasing the concentration of acetylcholine through reversible inhibition of its hydrolysis by acetylcholinesterase.
  • Manufacturer: Eisai Pharma

Sources:

Related Videos
Image credit: K KStock | stock.adobe.com
Image credit: komokvm | stock.adobe.com
Vial of Pneumococcal vaccine - Image credit: Bernard Chantal | stock.adobe.com
Vaccine vials used for Respiratory Syncytial Virus (RSV) with a syringe - Image credit:  Peter Hansen | stock.adobe.com
Older patient with medical health checkup with cardiologist or geriatric doctor. Woman with coronary artery heart disease or cardiac illness check-up in clinic - Image credit: Chinnapong | stock.adobe.com